rs146157250

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001291303.3(FAT4):​c.7935C>T​(p.Asp2645Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,613,590 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 6 hom. )

Consequence

FAT4
NM_001291303.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0550

Publications

1 publications found
Variant links:
Genes affected
FAT4 (HGNC:23109): (FAT atypical cadherin 4) The protein encoded by this gene is a member of the protocadherin family. This gene may play a role in regulating planar cell polarity (PCP). Studies in mice suggest that loss of PCP signaling may cause cystic kidney disease, and mutations in this gene have been associated with Van Maldergem Syndrome 2. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Mar 2014]
FAT4 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • van Maldergem syndrome 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • multiple congenital anomalies/dysmorphic syndrome-intellectual disability
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • van Maldergem syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 4-125448945-C-T is Benign according to our data. Variant chr4-125448945-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 435173.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.055 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00242 (368/152190) while in subpopulation AMR AF = 0.00813 (124/15254). AF 95% confidence interval is 0.00697. There are 4 homozygotes in GnomAd4. There are 184 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAT4NM_001291303.3 linkc.7935C>T p.Asp2645Asp synonymous_variant Exon 10 of 18 ENST00000394329.9 NP_001278232.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAT4ENST00000394329.9 linkc.7935C>T p.Asp2645Asp synonymous_variant Exon 10 of 18 5 NM_001291303.3 ENSP00000377862.4
FAT4ENST00000335110.5 linkc.2823C>T p.Asp941Asp synonymous_variant Exon 9 of 15 1 ENSP00000335169.5
FAT4ENST00000674496.2 linkc.2706C>T p.Asp902Asp synonymous_variant Exon 9 of 17 ENSP00000501473.2

Frequencies

GnomAD3 genomes
AF:
0.00242
AC:
368
AN:
152072
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00348
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00814
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00118
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00145
AC:
362
AN:
249612
AF XY:
0.00124
show subpopulations
Gnomad AFR exome
AF:
0.00358
Gnomad AMR exome
AF:
0.00377
Gnomad ASJ exome
AF:
0.00209
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.00346
GnomAD4 exome
AF:
0.00101
AC:
1469
AN:
1461400
Hom.:
6
Cov.:
41
AF XY:
0.000971
AC XY:
706
AN XY:
726980
show subpopulations
African (AFR)
AF:
0.00317
AC:
106
AN:
33466
American (AMR)
AF:
0.00385
AC:
172
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
38
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86248
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53166
Middle Eastern (MID)
AF:
0.00537
AC:
31
AN:
5768
European-Non Finnish (NFE)
AF:
0.000878
AC:
976
AN:
1111872
Other (OTH)
AF:
0.00227
AC:
137
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
89
178
267
356
445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00242
AC:
368
AN:
152190
Hom.:
4
Cov.:
32
AF XY:
0.00247
AC XY:
184
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00347
AC:
144
AN:
41522
American (AMR)
AF:
0.00813
AC:
124
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00118
AC:
80
AN:
68020
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
17
33
50
66
83
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00147
Hom.:
1
Bravo
AF:
0.00305

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 23, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FAT4: BP4, BP7, BS2 -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Sep 14, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FAT4-related disorder Benign:1
Jul 17, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
2.6
DANN
Benign
0.40
PhyloP100
0.055
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146157250; hg19: chr4-126370100; COSMIC: COSV58710374; COSMIC: COSV58710374; API